Guinea-Bissau suspends Trump-backed hepatitis B vaccine study for ethical review

By WILSON MCMAKIN

DAKAR, Senegal (AP) — Guinea-Bissau is suspending a Trump administration-backed hepatitis B vaccine study on newborns in the West African country, pending an ethical review, the health minister said Thursday.

Related Articles

• Trump administration halts use of human fetal tissue in NIH-funded research
• What to know about FDA’s review of new Zyn advertising proposal
• Red Cross asks for donations amid ‘severe’ blood shortages
• Read Entire Article